Agilent Technologies, Inc. income statement A

Annual Quarterly

In fiscal 2025, which ended Oct 31, 2025, Agilent Technologies, Inc. reported revenue of $6.9 billion, up 6.7% from the year before. Net income was $1.3 billion, a profit margin of 18.8%. Operating income came to $1.5 billion, an operating margin of 21.3%. Diluted earnings per share were $4.57. Over the twelve months ended Jul 31, 2026, revenue was $7.4 billion and net income was $1.4 billion. Across the 10 fiscal years shown, revenue grew from $4.2 billion in fiscal 2016 to $6.9 billion in fiscal 2025, about 5.7% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

FY 2026
Jul 31, 2026
FY 2025
Oct 31, 2025
FY 2024
Oct 31, 2024
FY 2023
Oct 31, 2023
FY 2022
Oct 31, 2022
FY 2021
Oct 31, 2021
FY 2020
Oct 31, 2020
FY 2019
Oct 31, 2019
FY 2018
Oct 31, 2018
FY 2017
Oct 31, 2017
FY 2016
Oct 31, 2016
Revenue
7,372
+8.6%
6,948
+6.7%
6,510
-4.7%
6,833
-0.2%
6,848
+8.4%
6,319
+18.4%
5,339
+3.4%
5,163
+5.1%
4,914
+9.9%
4,472
+6.4%
4,202
+4.1%
Cost of revenue
3,404
+5.7%
3,305
+11.1%
2,975
-11.7%
3,368
+7.7%
3,126
+7.3%
2,912
+16.4%
2,502
+6.1%
2,358
+5.6%
2,234
+8.3%
2,063
+2.9%
2,005
+0.4%
Gross profit
3,968
+11.2%
3,643
+3.1%
3,535
+2.0%
3,465
-6.9%
3,722
+9.2%
3,407
+20.1%
2,837
+1.1%
2,805
+4.7%
2,680
+11.2%
2,409
+9.6%
2,197
+7.6%
Research and development
485
+8.5%
455
-5.0%
479
-0.4%
481
+3.0%
467
+5.9%
441
-10.9%
495
+22.5%
404
+4.4%
387
+13.5%
341
+3.6%
329
-0.3%
Selling, general and administrative
1,844
+9.9%
1,709
+9.0%
1,568
-4.0%
1,634
-0.2%
1,637
+1.1%
1,619
+8.2%
1,496
+2.5%
1,460
+5.1%
1,389
+11.0%
1,251
-0.2%
1,253
+5.4%
Restructuring and impairment
51
-35.4%
82
+7.9%
76
+65.2%
46
—
—
—
—
—
—
—
Operating income
1,639
+13.5%
1,479
-0.6%
1,488
+10.2%
1,350
-16.6%
1,618
+20.1%
1,347
+59.2%
846
-10.1%
941
+4.1%
904
+12.0%
807
+31.2%
615
+17.8%
Interest income
60
-13.0%
62
-22.5%
80
+56.9%
51
+466.7%
9
+350.0%
2
-75.0%
8
-77.8%
36
-5.3%
38
+72.7%
22
+100.0%
11
+57.1%
Interest expense
106
-9.4%
112
+16.7%
96
+1.1%
95
+13.1%
84
+3.7%
81
+3.8%
78
+5.4%
74
-1.3%
75
-5.1%
79
+9.7%
72
+9.1%
Other non-operating income (expense)
65
+3350.0%
6
-87.8%
49
+48.5%
33
+184.6%
-39
-142.4%
92
+39.4%
66
+312.5%
16
-79.7%
79
+49.1%
53
+630.0%
-10
-158.8%
Pretax income
1,658
+18.9%
1,435
-5.7%
1,521
+13.6%
1,339
-11.0%
1,504
+10.6%
1,360
+61.5%
842
-8.4%
919
-2.9%
946
+17.8%
803
+47.6%
544
-29.1%
Income tax
218
+25.3%
132
-43.1%
232
+134.3%
99
-60.4%
250
+66.7%
150
+22.0%
123
+180.9%
-152
-124.1%
630
+429.4%
119
+45.1%
82
+95.2%
Net income
1,440
+18.0%
1,303
+1.1%
1,289
+4.0%
1,240
-1.1%
1,254
—
—
—
—
—
—
Basic EPS
5.10
+19.0%
4.59
+3.4%
4.44
+5.2%
4.22
+0.7%
4.19
+5.3%
3.98
+70.8%
2.33
-31.7%
3.41
+248.0%
0.98
-53.8%
2.12
+49.3%
1.42
+18.3%
Diluted EPS
5.08
+18.7%
4.57
+3.2%
4.43
+5.7%
4.19
+0.2%
4.18
+6.1%
3.94
+71.3%
2.30
-31.8%
3.37
+247.4%
0.97
-53.8%
2.10
+50.0%
1.40
+16.7%
Weighted average shares, basic
283
-0.8%
284
-2.1%
290
-1.4%
294
-1.7%
299
-1.6%
304
-1.6%
309
-1.6%
314
-2.2%
321
-0.3%
322
-1.2%
326
-2.1%
Weighted average shares, diluted
284
-0.5%
285
-2.1%
291
-1.7%
296
-1.3%
300
-2.3%
307
-1.6%
312
-1.9%
318
-2.2%
325
-0.3%
326
-0.9%
329
-1.8%
Other measures
Depreciation and amortization
271
-5.2%
288
+12.1%
257
-5.2%
271
-14.5%
317
-1.2%
321
+4.2%
308
+29.4%
238
+13.3%
210
-0.9%
212
-13.8%
246
-2.8%
EBITDA
1,910
+10.4%
1,767
+1.3%
1,745
+7.6%
1,621
-16.2%
1,935
+16.0%
1,668
+44.5%
1,154
-2.1%
1,179
+5.8%
1,114
+9.3%
1,019
+18.4%
861
+11.1%
Interest coverage
15.46x
13.21x
15.50x
14.21x
19.26x
16.63x
10.85x
12.72x
12.05x
10.22x
8.54x
Margins
Gross margin
53.83%
52.43%
54.30%
50.71%
54.35%
53.92%
53.14%
54.33%
54.54%
53.87%
52.28%
Operating margin
22.23%
21.29%
22.86%
19.76%
23.63%
21.32%
15.85%
18.23%
18.40%
18.05%
14.64%
Pretax margin
22.49%
20.65%
23.36%
19.60%
21.96%
21.52%
15.77%
17.80%
19.25%
17.96%
12.95%
Profit margin
19.53%
18.75%
19.80%
18.15%
18.31%
—
—
—
—
—
—
EBITDA margin
25.91%
25.43%
26.80%
23.72%
28.26%
26.40%
21.61%
22.84%
22.67%
22.79%
20.49%
Effective tax rate
13.15%
9.20%
15.25%
7.39%
16.62%
11.03%
14.61%
-16.54%
66.60%
14.82%
15.07%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry
Laboratory Analytical Instruments (SIC 3826)
Listed as
A (NYSE)
Fiscal year ends
October 31
Incorporated in
DE
Headquarters
Santa Clara, CA
SEC filer status
Large accelerated filer
SEC CIK
1090872
Former names
AGILENT TECHNOLOGIES INC (until Sep 16, 2019)

Other Laboratory Analytical Instruments companies

All 25 Laboratory Analytical Instruments companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.